Malaria vaccine booster trial aims to keep school kids protected
NCT ID NCT07074665
First seen Feb 28, 2026 · Last updated May 19, 2026 · Updated 11 times
Summary
This study tests a booster dose of the R21/Matrix-M malaria vaccine in 30-40 school children in Burkina Faso who already received four doses years earlier. Researchers want to see if a booster is safe and how well it boosts immunity, comparing two different doses. The goal is to help protect children from malaria as they grow older.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (PLASMODIUM FALCIPARUM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unité de Recherche Clinique de Nanoro (URCN)
RECRUITINGNanoro, PO Box 11 BP 218 Ouaga CMS 11, Burkina Faso
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.